Cargando…
Harnessing the Therapeutic Potential of Decoys in Non-Atherosclerotic Cardiovascular Diseases: State of the Art
Cardiovascular disease (CVD) is the main cause of global death, highlighting the fact that conventional therapeutic approaches for the treatment of CVD patients are insufficient, and there is a need to develop new therapeutic approaches. In recent years, decoy technology, decoy oligodeoxynucleotides...
Autores principales: | Mahjoubin-Tehran, Maryam, Atkin, Stephen L., Bezsonov, Evgeny E., Jamialahmadi, Tannaz, Sahebkar, Amirhossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467637/ https://www.ncbi.nlm.nih.gov/pubmed/34564121 http://dx.doi.org/10.3390/jcdd8090103 |
Ejemplares similares
-
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2020) -
Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2021) -
Harnessing Therapeutic Potentials of Statins Using Nanofibrous Carriers
por: Ataei, Mahshid, et al.
Publicado: (2021) -
The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
por: Moosavian, Seyedeh Alia, et al.
Publicado: (2021) -
Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art
por: Yaribeygi, Habib, et al.
Publicado: (2023)